Chen J-G et al. (1998) Population-based cancer survival in Qidong, People's Republic of China. IARC Scientific Publications 145: 27-35.
Council for Agricultural Science and Technology (CAST) (2003) Mycotoxins: Risks in Plants, Animals and Human Systems. Washington, DC: CAST.
Etzel RA (2002) Mycotoxins. Journal of the American Medical Association 287: 425-427.
Harris CC (1996) p53 tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective. Carcinogenesis 17: 1187-1198.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1993) Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins, vol. 56. Lyon, France: IARC.
Jackson PE, Qian G-S, Friesen MD et al. (2001) Specific p53 mutation detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectro-metry. Cancer Research 61: 33-35.
Kirk GD, Camus-Randon AM, Mendy M et al. (2000) Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. Journal of the National Cancer Institute 92: 148-153.
Li L and Rao K (eds.) (2001) Cancer Incidence and Mortality in Cities and Counties of P. R. China 1988-1992. China Medical Science and Technology Press.
Lye MS, Ghazali AA, Mohan J, Alwin N, and Nair RC (1995) An outbreak of acute hepatic encephalopathy due to several afla-toxicosis in Malaysia. American Journal of Tropical Medicine and Hygene 53: 68-72.
Park D and Troxell T (2002) US perspective on mycotoxin regulatory issues. Advances in Experimental Medicine and Biology 504: 277-285.
Parkin DM, Pisani P, and Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. International Journal of Cancer 80: 827-841.
Sun Z-T et al. (1999) Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology 30: 379-383.
Wang L-Y, Hatch M, Chen CJ et al. (1996) Aflatoxin exposure and the risk of hepatocellular carcinoma in Taiwan. International Journal of Cancer 67: 620-625.
Wild CP and Turner PC (2002) The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis 17: 471-481.
Yu MW, Lien JP, Chiu YH et al. (1997) Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. Journal of Hepatology 27: 320-330.
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.